Clinique de Chirurgie Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, University Hospital of Nantes - Hotel Dieu, Nantes, France.
Dis Colon Rectum. 2011 Apr;54(4):425-32. doi: 10.1007/DCR.0b013e318200f866.
Sacral nerve stimulation fails in 30% to 50% of patients, the outcome that remains largely unreported.
We report on the management and outcome of this cohort of patients.
Ninety-one patients (88 females) with fecal incontinence, median age 63 years (range, 37-81), were candidates for sacral nerve stimulation. The follow-up protocol comprised incontinence and quality-of-life scores.
Failure was defined on an intention-to-treat basis: after the test (<50% decrease of fecal incontinence episodes) or after permanent implantation (Wexner score >8). Subsequent management and functional results were recorded.
The mean Wexner score for the cohort decreased from 14.3 at baseline to 7.6 after a median follow-up of 31 months (range, 11-69). Sixty-one (67.0%) patients were implanted with a permanent pacemaker; 36 (39.6%) achieved success (group 1). Failure after permanent implantation occurred in 25 (27.5%) patients after a mean of 34.5 months (group 2). Failure after the test occurred in 30 (33.0%) patients, 12 of whom underwent further surgery (group 3) (including stoma, 2; anal reconstruction, 9; and rectopexy, 1), whereas the remainder chose conservative treatment (group 4). At the end of follow-up, group 1 had significantly lower Wexner scores compared with the rest (P < .0001) and superior Fecal Incontinence Quality of Life scores compared with groups 2 and 4 (P < .0001). Group 3 achieved a greater reduction in Wexner scores compared with groups 2 and 4 (P = .04), although the improvement in Fecal Incontinence Quality of Life scores did not reach statistical significance.
This was a nonrandomized study with retrospective stratification of patients.
On an intention-to-treat basis, success can be achieved in up to 40% of patients undergoing sacral nerve stimulation. In those in whom sacral nerve stimulation fails, further surgical treatment can yield favorable results in adequately motivated patients.
骶神经刺激在 30%至 50%的患者中失败,其结果在很大程度上仍未得到报告。
我们报告了这组患者的治疗和结果。
91 名(88 名女性)患有粪便失禁的患者,中位年龄 63 岁(范围,37-81 岁),是骶神经刺激的候选者。随访方案包括失禁和生活质量评分。
以意向治疗为基础定义失败:测试后(粪便失禁发作减少<50%)或永久植入后(Wexner 评分>8)。随后记录了管理和功能结果。
该队列的平均 Wexner 评分从基线时的 14.3 分降至中位数随访 31 个月(范围,11-69)后的 7.6 分。61 名(67.0%)患者植入了永久性起搏器;36 名(39.6%)患者获得成功(第 1 组)。25 名(27.5%)患者在平均 34.5 个月后(第 2 组)出现永久性植入后失败。30 名(33.0%)患者在测试后失败,其中 12 名患者接受了进一步手术(第 3 组)(包括造口术 2 例;肛门重建术 9 例;直肠固定术 1 例),而其余患者选择了保守治疗(第 4 组)。在随访结束时,第 1 组的 Wexner 评分明显低于其他组(P<.0001),并且 Fecal Incontinence Quality of Life 评分明显优于第 2 组和第 4 组(P<.0001)。第 3 组的 Wexner 评分与第 2 组和第 4 组相比有更大的降低(P=.04),尽管 Fecal Incontinence Quality of Life 评分的改善未达到统计学意义。
这是一项非随机研究,对患者进行了回顾性分层。
在意向治疗的基础上,接受骶神经刺激的患者中多达 40%可以获得成功。在骶神经刺激失败的患者中,进一步的手术治疗可以为有意愿的患者带来良好的结果。